Novo Nordisk aims for heavy sales in India with Wegovy

The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record for prescription brand sales. Keytruda, a breakthrough anti-cancer drug from MSD India (part of the US Merck group), is currently the No. 1 in prescription brands, with annual revenue exceeding Rs 1,600 crore, according to market sources.